Panagora Asset Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-356,740
| Closed | -$1.33M | – | 1219 |
|
|
2023
Q4 | $1.33M | Sell |
356,740
-69,845
| -16% | -$261K | 0.01% | 709 |
|
|
2023
Q3 | $904K | Buy |
426,585
+107,098
| +34% | +$227K | 0.01% | 808 |
|
|
2023
Q2 | $1.52M | Sell |
319,487
-5,874
| -2% | -$28K | 0.01% | 644 |
|
|
2023
Q1 | $1.85M | Buy |
325,361
+5,041
| +2% | +$28.7K | 0.01% | 597 |
|
|
2022
Q4 | $3.23M | Buy |
320,320
+22,042
| +7% | +$222K | 0.02% | 481 |
|
|
2022
Q3 | $6.68M | Sell |
298,278
-2,374
| -0.8% | -$53.2K | 0.05% | 301 |
|
|
2022
Q2 | $7.45M | Buy |
300,652
+25,207
| +9% | +$625K | 0.05% | 301 |
|
|
2022
Q1 | $10.7M | Buy |
275,445
+616
| +0.2% | +$23.9K | 0.06% | 278 |
|
|
2021
Q4 | $16.1M | Buy |
274,829
+9,456
| +4% | +$553K | 0.09% | 217 |
|
|
2021
Q3 | $15.7M | Buy |
265,373
+33,473
| +14% | +$1.98M | 0.08% | 224 |
|
|
2021
Q2 | $20.1M | Buy |
231,900
+69,304
| +43% | +$6.02M | 0.11% | 193 |
|
|
2021
Q1 | $13.4M | Buy |
+162,596
| New | +$13.4M | 0.08% | 245 |
|
|
2018
Q3 | – | Sell |
-6,275
| Closed | -$71K | – | 2426 |
|
|
2018
Q2 | $71K | Sell |
6,275
-4,964
| -44% | -$56.2K | ﹤0.01% | 1958 |
|
|
2018
Q1 | $110K | Sell |
11,239
-12,224
| -52% | -$120K | ﹤0.01% | 1832 |
|
|
2017
Q4 | $143K | Sell |
23,463
-32
| -0.1% | -$195 | ﹤0.01% | 1775 |
|
|
2017
Q3 | $93K | Sell |
23,495
-6,015
| -20% | -$23.8K | ﹤0.01% | 1906 |
|
|
2017
Q2 | $96K | Hold |
29,510
| – | – | ﹤0.01% | 1886 |
|
|
2017
Q1 | $134K | Hold |
29,510
| – | – | ﹤0.01% | 1778 |
|
|
2016
Q4 | $74K | Hold |
29,510
| – | – | ﹤0.01% | 2019 |
|
|
2016
Q3 | $92K | Buy |
+29,510
| New | +$92K | ﹤0.01% | 1987 |
|